相关实验视频
Updated: Jan 9, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
染色体重塑因子CHRAC1通过IRF9/GSDMD/CASP-1调节多克索鲁比诱导的心脏毒性
Tongtong Zang1, Changyi Zhou1, Yue Yu1
1Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, China; State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China; NHC Key Laboratory of Ischemic Heart Diseases, China; Key Laboratory of Viral Heart Diseases, Chinese Academy of Medical Sciences, China; National Clinical Research Center for Interventional Medicine, Shanghai, China; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
doxorubicin 诱导的心脏毒性 (DIC) 是癌症治疗的严重副作用. 研究人员发现,表观遗传调节器CHRAC1通过激活IRF9通路来驱动DIC,导致细胞死亡,提供了一个新的治疗点.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 心血管生物学 心血管生物学
- 癌症治疗并发症 癌症治疗并发症
背景情况:
- doxorubicin 诱导的心脏毒性 (DIC) 是一个重要的临床挑战.
- 在DIC中表观遗传调节者的作用尚不清楚.
研究的目的:
- 为了确定DIC的新型表观遗传决定因素.
- 阐明CHRAC1在DIC中的作用背后的分子机制.
主要方法:
- 利用小鼠和细胞模型研究CHRAC1在DIC中的功能.
- 进行了集成RNA测序和ATAC测序.
- 采用基因沉默技术 (siRNA) 来评估下游影响.
主要成果:
- 通过CHRAC1的敲除,可以保护心脏功能和细胞活力,减少活性氧物种和心肌细胞死亡.
- CHRAC1过度表达加剧了心脏损伤和细胞死亡.
- 发现CHRAC1通过转录激活了NOD类受体信号通路,IRF9作为关键调解器.
- 沉默IRF9可以逆转CHRAC1诱导的病态表型.
结论:
- 通过对IRF9.9的转录调节,CHRAC1促进了卡斯巴-1-依赖性热.
- 这项研究揭示了一个新的表观遗传-免疫信号网络 (CHRAC1-IRF9-pyroptosis轴).
- CHRAC1-IRF9-pyroptosis轴代表了预防和治疗antracycline心脏毒性的潜在治疗目标.
相关概念视频
Regulation of the Unfolded Protein Response
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Homologous Recombination
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...

